

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09190343 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.95204836 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.95204836 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.72450974 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.72450974 |
| 6 | hemidesmosome assembly (GO:0031581) | 4.65833773 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 4.43648015 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 4.39983687 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.31832482 |
| 10 | cell-substrate junction assembly (GO:0007044) | 4.30031211 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.18005659 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.11835716 |
| 13 | endodermal cell differentiation (GO:0035987) | 4.11508978 |
| 14 | cellular modified amino acid catabolic process (GO:0042219) | 4.06966488 |
| 15 | protein localization to endosome (GO:0036010) | 4.05590849 |
| 16 | skin morphogenesis (GO:0043589) | 4.02177401 |
| 17 | basement membrane organization (GO:0071711) | 3.98781879 |
| 18 | cell adhesion mediated by integrin (GO:0033627) | 3.98559701 |
| 19 | protein carboxylation (GO:0018214) | 3.95106772 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95106772 |
| 21 | regulation of fibrinolysis (GO:0051917) | 3.93230367 |
| 22 | bile acid biosynthetic process (GO:0006699) | 3.92476712 |
| 23 | glyoxylate metabolic process (GO:0046487) | 3.90719767 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.83985093 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.83985093 |
| 26 | lysine catabolic process (GO:0006554) | 3.80270294 |
| 27 | lysine metabolic process (GO:0006553) | 3.80270294 |
| 28 | urea metabolic process (GO:0019627) | 3.78676909 |
| 29 | urea cycle (GO:0000050) | 3.78676909 |
| 30 | coenzyme catabolic process (GO:0009109) | 3.78576925 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 3.77026539 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 3.77026539 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.77026539 |
| 34 | complement activation, alternative pathway (GO:0006957) | 3.76228719 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.76225183 |
| 36 | adherens junction assembly (GO:0034333) | 3.75856991 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.75119799 |
| 38 | cysteine metabolic process (GO:0006534) | 3.70869647 |
| 39 | regulation of cholesterol homeostasis (GO:2000188) | 3.69810031 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 3.67866763 |
| 41 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.64721674 |
| 42 | cell-substrate adherens junction assembly (GO:0007045) | 3.62184435 |
| 43 | focal adhesion assembly (GO:0048041) | 3.62184435 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62048194 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 3.58125242 |
| 46 | tryptophan metabolic process (GO:0006568) | 3.55961445 |
| 47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.55300699 |
| 48 | regulation of complement activation (GO:0030449) | 3.53505140 |
| 49 | homocysteine metabolic process (GO:0050667) | 3.45293467 |
| 50 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.43692649 |
| 51 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43248535 |
| 52 | reverse cholesterol transport (GO:0043691) | 3.41093579 |
| 53 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.37773194 |
| 54 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.37747295 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 3.36476901 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.36445188 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.36445188 |
| 58 | desmosome organization (GO:0002934) | 3.35887743 |
| 59 | stress fiber assembly (GO:0043149) | 3.33865820 |
| 60 | bile acid metabolic process (GO:0008206) | 3.31689638 |
| 61 | epithelial cell-cell adhesion (GO:0090136) | 3.30404204 |
| 62 | negative regulation of fatty acid transport (GO:2000192) | 3.30024414 |
| 63 | hormone catabolic process (GO:0042447) | 3.29003914 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 3.28299835 |
| 65 | collagen fibril organization (GO:0030199) | 3.27232480 |
| 66 | protein retention in ER lumen (GO:0006621) | 3.26688215 |
| 67 | glutamate metabolic process (GO:0006536) | 3.24444411 |
| 68 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.20586342 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.20509626 |
| 70 | protein heterotrimerization (GO:0070208) | 3.19756463 |
| 71 | semaphorin-plexin signaling pathway (GO:0071526) | 3.17759143 |
| 72 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16755159 |
| 73 | ethanol oxidation (GO:0006069) | 3.16101911 |
| 74 | barbed-end actin filament capping (GO:0051016) | 3.13568182 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.10686102 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.09799524 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 3.08818520 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.08324647 |
| 79 | chondrocyte proliferation (GO:0035988) | 3.07989926 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.07805850 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 3.06521385 |
| 82 | protein-lipid complex remodeling (GO:0034368) | 3.05581690 |
| 83 | macromolecular complex remodeling (GO:0034367) | 3.05581690 |
| 84 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05581690 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.05399740 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.05399740 |
| 87 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.04016723 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.03390763 |
| 89 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03093232 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.00939654 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 2.99646545 |
| 92 | aromatic amino acid family metabolic process (GO:0009072) | 2.98148936 |
| 93 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.96965448 |
| 94 | midgut development (GO:0007494) | 2.93914208 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.93391839 |
| 96 | phospholipid efflux (GO:0033700) | 2.92467955 |
| 97 | cholesterol efflux (GO:0033344) | 2.89366941 |
| 98 | cell migration involved in heart development (GO:0060973) | 2.88174925 |
| 99 | collagen metabolic process (GO:0032963) | 2.87923821 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 2.87485027 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 2.86633484 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85973038 |
| 103 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.85540137 |
| 104 | substrate-dependent cell migration (GO:0006929) | 2.84038703 |
| 105 | endothelial cell morphogenesis (GO:0001886) | 2.84007784 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82986329 |
| 107 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.82108698 |
| 108 | drug catabolic process (GO:0042737) | 2.80971477 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79940470 |
| 110 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.79261865 |
| 111 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.78402863 |
| 112 | extracellular matrix disassembly (GO:0022617) | 2.77081214 |
| 113 | wound healing, spreading of epidermal cells (GO:0035313) | 2.75571695 |
| 114 | ketone body metabolic process (GO:1902224) | 2.74864737 |
| 115 | regulation of cholesterol esterification (GO:0010872) | 2.74158265 |
| 116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.73919952 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 2.73447367 |
| 118 | extracellular matrix assembly (GO:0085029) | 2.73217693 |
| 119 | fibrinolysis (GO:0042730) | 2.72191146 |
| 120 | aspartate family amino acid catabolic process (GO:0009068) | 2.71773150 |
| 121 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.71458786 |
| 122 | bile acid and bile salt transport (GO:0015721) | 2.71025221 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 2.70508714 |
| 124 | positive regulation of osteoblast proliferation (GO:0033690) | 2.69162632 |
| 125 | plasma lipoprotein particle assembly (GO:0034377) | 2.69102892 |
| 126 | collagen catabolic process (GO:0030574) | 2.69072785 |
| 127 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.67925880 |
| 128 | lipoprotein metabolic process (GO:0042157) | 2.67166583 |
| 129 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.66970039 |
| 130 | extracellular fibril organization (GO:0043206) | 2.66531282 |
| 131 | surfactant homeostasis (GO:0043129) | 2.66216804 |
| 132 | linoleic acid metabolic process (GO:0043651) | 2.65375619 |
| 133 | drug metabolic process (GO:0017144) | 2.64626351 |
| 134 | protein-lipid complex assembly (GO:0065005) | 2.64333975 |
| 135 | fatty acid transmembrane transport (GO:1902001) | 2.62864850 |
| 136 | blood vessel endothelial cell migration (GO:0043534) | 2.61823793 |
| 137 | regulation of plasminogen activation (GO:0010755) | 2.60830137 |
| 138 | wound healing, spreading of cells (GO:0044319) | 2.60734209 |
| 139 | cholesterol homeostasis (GO:0042632) | 2.59410000 |
| 140 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.59364491 |
| 141 | bone trabecula formation (GO:0060346) | 2.59047310 |
| 142 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.59038094 |
| 143 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.58676960 |
| 144 | cortical actin cytoskeleton organization (GO:0030866) | 2.58385541 |
| 145 | complement activation, classical pathway (GO:0006958) | 2.58344624 |
| 146 | sterol homeostasis (GO:0055092) | 2.57524657 |
| 147 | type B pancreatic cell proliferation (GO:0044342) | 2.56971641 |
| 148 | atrioventricular valve morphogenesis (GO:0003181) | 2.56583328 |
| 149 | multicellular organismal metabolic process (GO:0044236) | 2.55974035 |
| 150 | short-chain fatty acid metabolic process (GO:0046459) | 2.55810060 |
| 151 | cellular glucuronidation (GO:0052695) | 2.55513825 |
| 152 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.55133930 |
| 153 | negative regulation of lipase activity (GO:0060192) | 2.54120021 |
| 154 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.53876413 |
| 155 | biotin metabolic process (GO:0006768) | 2.53314145 |
| 156 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.53165521 |
| 157 | complement activation (GO:0006956) | 2.52688361 |
| 158 | valine metabolic process (GO:0006573) | 2.52513289 |
| 159 | indolalkylamine metabolic process (GO:0006586) | 2.51920501 |
| 160 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.51500947 |
| 161 | axon extension involved in axon guidance (GO:0048846) | 2.51500947 |
| 162 | carboxylic acid catabolic process (GO:0046395) | 2.51162536 |
| 163 | organic acid catabolic process (GO:0016054) | 2.51162536 |
| 164 | negative regulation of protein activation cascade (GO:2000258) | 2.51084973 |
| 165 | cellular response to vitamin (GO:0071295) | 2.50136286 |
| 166 | paraxial mesoderm development (GO:0048339) | 2.47885667 |
| 167 | multicellular organismal catabolic process (GO:0044243) | 2.47738128 |
| 168 | hypotonic response (GO:0006971) | 2.46527338 |
| 169 | endocytic recycling (GO:0032456) | 2.45237516 |
| 170 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.44934573 |
| 171 | adhesion of symbiont to host (GO:0044406) | 2.44348740 |
| 172 | hyaluronan catabolic process (GO:0030214) | 2.42827143 |
| 173 | fibril organization (GO:0097435) | 2.41914632 |
| 174 | regulation of establishment of planar polarity (GO:0090175) | 2.41596601 |
| 175 | venous blood vessel morphogenesis (GO:0048845) | 2.40936881 |
| 176 | positive regulation of extracellular matrix organization (GO:1903055) | 2.40936256 |
| 177 | protein targeting to plasma membrane (GO:0072661) | 2.40412137 |
| 178 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.40035236 |
| 179 | mesodermal cell differentiation (GO:0048333) | 2.39307871 |
| 180 | actin filament depolymerization (GO:0030042) | 2.39180155 |
| 181 | virion attachment to host cell (GO:0019062) | 2.39034361 |
| 182 | adhesion of symbiont to host cell (GO:0044650) | 2.39034361 |
| 183 | pinocytosis (GO:0006907) | 2.38754044 |
| 184 | actin filament bundle organization (GO:0061572) | 2.38717771 |
| 185 | actin filament bundle assembly (GO:0051017) | 2.38717771 |
| 186 | glomerular basement membrane development (GO:0032836) | 2.36702927 |
| 187 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.36373873 |
| 188 | extracellular matrix organization (GO:0030198) | 2.35645579 |
| 189 | adherens junction organization (GO:0034332) | 2.34570265 |
| 190 | extracellular structure organization (GO:0043062) | 2.34547953 |
| 191 | cell junction assembly (GO:0034329) | 2.34270494 |
| 192 | cortical cytoskeleton organization (GO:0030865) | 2.32262126 |
| 193 | vesicle coating (GO:0006901) | 2.32182741 |
| 194 | endothelial cell chemotaxis (GO:0035767) | 2.31789049 |
| 195 | membrane protein ectodomain proteolysis (GO:0006509) | 2.31445382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.22552740 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.67926689 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.05261356 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.94797368 |
| 5 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.17005407 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04790551 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96625020 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.25952628 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09717071 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04494719 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85310460 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81882309 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79658870 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68313987 |
| 15 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.64197843 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62750552 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62726515 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61555920 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58605933 |
| 20 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55872300 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53707444 |
| 22 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.53105656 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.51277159 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49243860 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46884577 |
| 26 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46112572 |
| 27 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.45655352 |
| 28 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.45008619 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43898086 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42335378 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40396089 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39844088 |
| 33 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.39480502 |
| 34 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39236502 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38801617 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37817316 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36962218 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36911441 |
| 39 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35916256 |
| 40 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35916256 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30162729 |
| 42 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28218546 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27118569 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25470016 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24965075 |
| 46 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22887163 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22301560 |
| 48 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22224292 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21454150 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21302226 |
| 51 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.21243294 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20561487 |
| 53 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19299158 |
| 54 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17953300 |
| 55 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17483159 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16154508 |
| 57 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.15407610 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14121431 |
| 59 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13901490 |
| 60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12742246 |
| 61 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12494233 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12449246 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12389105 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11671771 |
| 65 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11384883 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10969554 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10214239 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09790071 |
| 69 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09532406 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09317033 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08762176 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08048346 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07632570 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07632570 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07058086 |
| 76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06983648 |
| 77 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06242562 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04877731 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02759080 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02620491 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02190570 |
| 82 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02090312 |
| 83 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02090312 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01621509 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01269436 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01027104 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00599021 |
| 88 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99307299 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99280047 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98837181 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97968021 |
| 92 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97681849 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97591422 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97480535 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96689919 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96411756 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95789674 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95125522 |
| 99 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94726952 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94397720 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94277674 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94246029 |
| 103 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94094798 |
| 104 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94046410 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93209175 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92953411 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92664776 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92514901 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92403782 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92082746 |
| 111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91289172 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91231578 |
| 113 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91114367 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90713492 |
| 115 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90485046 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88171691 |
| 117 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86737457 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86528240 |
| 119 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.85653724 |
| 120 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85653724 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.85653724 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85579851 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84895751 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84573513 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84382932 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84382932 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83920261 |
| 128 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83899332 |
| 129 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.82700412 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82361122 |
| 131 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81058656 |
| 132 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80275650 |
| 133 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79880353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.15849825 |
| 2 | MP0005360_urolithiasis | 5.79665068 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.44867856 |
| 4 | MP0005365_abnormal_bile_salt | 4.42764814 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.90151140 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.58819235 |
| 7 | MP0003252_abnormal_bile_duct | 3.49086168 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.86356803 |
| 9 | MP0005409_darkened_coat_color | 2.24666616 |
| 10 | MP0005083_abnormal_biliary_tract | 2.21732035 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.09995565 |
| 12 | MP0009840_abnormal_foam_cell | 2.09922492 |
| 13 | MP0001666_abnormal_nutrient_absorption | 1.98878750 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 1.93180996 |
| 15 | MP0010368_abnormal_lymphatic_system | 1.92038189 |
| 16 | MP0005332_abnormal_amino_acid | 1.90421566 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 1.86188160 |
| 18 | MP0002254_reproductive_system_inflammat | 1.81389481 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.76819050 |
| 20 | MP0000751_myopathy | 1.73920319 |
| 21 | MP0008961_abnormal_basal_metabolism | 1.72580888 |
| 22 | MP0003941_abnormal_skin_development | 1.70584586 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.66898380 |
| 24 | * MP0000609_abnormal_liver_physiology | 1.65577556 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.64858066 |
| 26 | MP0003195_calcinosis | 1.64273073 |
| 27 | MP0003011_delayed_dark_adaptation | 1.61387443 |
| 28 | MP0004858_abnormal_nervous_system | 1.57824290 |
| 29 | MP0004272_abnormal_basement_membrane | 1.51780579 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.46564432 |
| 31 | MP0005275_abnormal_skin_tensile | 1.46040146 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.42052790 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.41659124 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.41282660 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.39019271 |
| 36 | MP0005248_abnormal_Harderian_gland | 1.36808361 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.33706123 |
| 38 | MP0003868_abnormal_feces_composition | 1.31146110 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.29675952 |
| 40 | MP0005451_abnormal_body_composition | 1.29036920 |
| 41 | MP0004233_abnormal_muscle_weight | 1.27574715 |
| 42 | MP0006054_spinal_hemorrhage | 1.27349313 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.25051285 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.22742140 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.20614902 |
| 46 | MP0004130_abnormal_muscle_cell | 1.20566812 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.20461012 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.19054076 |
| 49 | MP0000467_abnormal_esophagus_morphology | 1.18368941 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.16393168 |
| 51 | MP0001542_abnormal_bone_strength | 1.15324809 |
| 52 | MP0001299_abnormal_eye_distance/ | 1.13964004 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.13455536 |
| 54 | MP0009053_abnormal_anal_canal | 1.13349890 |
| 55 | MP0001915_intracranial_hemorrhage | 1.13148168 |
| 56 | MP0006138_congestive_heart_failure | 1.12623244 |
| 57 | MP0001958_emphysema | 1.12411719 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.10626841 |
| 59 | MP0005595_abnormal_vascular_smooth | 1.07676775 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05273028 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.04448161 |
| 62 | MP0001849_ear_inflammation | 1.04172826 |
| 63 | MP0003283_abnormal_digestive_organ | 1.03552900 |
| 64 | MP0008260_abnormal_autophagy | 1.01895809 |
| 65 | * MP0000762_abnormal_tongue_morphology | 1.01050197 |
| 66 | MP0003329_amyloid_beta_deposits | 0.99142911 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.97201867 |
| 68 | MP0005501_abnormal_skin_physiology | 0.96902677 |
| 69 | MP0005187_abnormal_penis_morphology | 0.96027193 |
| 70 | MP0003828_pulmonary_edema | 0.95077214 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.94772104 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.94003140 |
| 73 | MP0003045_fibrosis | 0.93516548 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 0.93341617 |
| 75 | MP0005623_abnormal_meninges_morphology | 0.93311709 |
| 76 | MP0000604_amyloidosis | 0.93181229 |
| 77 | MP0000428_abnormal_craniofacial_morphol | 0.92296694 |
| 78 | MP0003279_aneurysm | 0.91445397 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.89669444 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.89577307 |
| 81 | MP0000462_abnormal_digestive_system | 0.89547746 |
| 82 | MP0001614_abnormal_blood_vessel | 0.89251397 |
| 83 | MP0003385_abnormal_body_wall | 0.89125432 |
| 84 | MP0000598_abnormal_liver_morphology | 0.88197320 |
| 85 | MP0002168_other_aberrant_phenotype | 0.88181651 |
| 86 | MP0000858_altered_metastatic_potential | 0.85496699 |
| 87 | MP0005023_abnormal_wound_healing | 0.83779443 |
| 88 | MP0005670_abnormal_white_adipose | 0.83138373 |
| 89 | MP0000534_abnormal_ureter_morphology | 0.82198157 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.81269470 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.81122375 |
| 92 | MP0003890_abnormal_embryonic-extraembry | 0.78726305 |
| 93 | MP0003115_abnormal_respiratory_system | 0.78130481 |
| 94 | MP0002925_abnormal_cardiovascular_devel | 0.77840265 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.77367607 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.77307695 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.75971535 |
| 98 | MP0001756_abnormal_urination | 0.75767858 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.75670760 |
| 100 | MP0003448_altered_tumor_morphology | 0.75535494 |
| 101 | MP0005390_skeleton_phenotype | 0.74546186 |
| 102 | MP0002249_abnormal_larynx_morphology | 0.74429107 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.73998708 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.73932473 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.73283504 |
| 106 | MP0009250_abnormal_appendicular_skeleto | 0.72774331 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.72352638 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.71293848 |
| 109 | MP0004087_abnormal_muscle_fiber | 0.71235855 |
| 110 | MP0002796_impaired_skin_barrier | 0.71202201 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.70871838 |
| 112 | MP0003690_abnormal_glial_cell | 0.69803653 |
| 113 | MP0010771_integument_phenotype | 0.68931392 |
| 114 | MP0005165_increased_susceptibility_to | 0.68848869 |
| 115 | MP0002269_muscular_atrophy | 0.68406636 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.67621619 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.67378432 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.66272628 |
| 119 | MP0005164_abnormal_response_to | 0.66233324 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.66059915 |
| 121 | * MP0005621_abnormal_cell_physiology | 0.65812283 |
| 122 | MP0000749_muscle_degeneration | 0.65781986 |
| 123 | MP0003942_abnormal_urinary_system | 0.65644717 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.65392175 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.65391997 |
| 126 | MP0000163_abnormal_cartilage_morphology | 0.64773924 |
| 127 | MP0000747_muscle_weakness | 0.64767662 |
| 128 | MP0002060_abnormal_skin_morphology | 0.63428831 |
| 129 | MP0004043_abnormal_pH_regulation | 0.62736044 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.62677471 |
| 131 | MP0002108_abnormal_muscle_morphology | 0.62301384 |
| 132 | MP0005503_abnormal_tendon_morphology | 0.62048535 |
| 133 | * MP0003091_abnormal_cell_migration | 0.61990368 |
| 134 | * MP0005388_respiratory_system_phenotype | 0.61458117 |
| 135 | * MP0002133_abnormal_respiratory_system | 0.61458117 |
| 136 | MP0005647_abnormal_sex_gland | 0.61453430 |
| 137 | MP0002932_abnormal_joint_morphology | 0.61149384 |
| 138 | MP0000579_abnormal_nail_morphology | 0.61047352 |
| 139 | MP0004883_abnormal_blood_vessel | 0.60779467 |
| 140 | * MP0003634_abnormal_glial_cell | 0.60350227 |
| 141 | MP0002090_abnormal_vision | 0.59918608 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.58773458 |
| 143 | MP0002928_abnormal_bile_duct | 0.58660076 |
| 144 | MP0000733_abnormal_muscle_development | 0.57922135 |
| 145 | MP0002128_abnormal_blood_circulation | 0.57061020 |
| 146 | MP0010030_abnormal_orbit_morphology | 0.55831417 |
| 147 | MP0005334_abnormal_fat_pad | 0.53819011 |
| 148 | MP0001243_abnormal_dermal_layer | 0.53552263 |
| 149 | MP0002971_abnormal_brown_adipose | 0.53276154 |
| 150 | MP0005330_cardiomyopathy | 0.52754103 |
| 151 | MP0005508_abnormal_skeleton_morphology | 0.51393893 |
| 152 | MP0003075_altered_response_to | 0.51275755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.90968411 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.50237721 |
| 3 | Xanthomatosis (HP:0000991) | 4.34409618 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.07358099 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.88812777 |
| 6 | Atrophic scars (HP:0001075) | 3.77029910 |
| 7 | Vascular tortuosity (HP:0004948) | 3.71867861 |
| 8 | Aortic dissection (HP:0002647) | 3.67168431 |
| 9 | Complement deficiency (HP:0004431) | 3.63369314 |
| 10 | Arterial tortuosity (HP:0005116) | 3.60003764 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.29703001 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.21750389 |
| 13 | Fragile skin (HP:0001030) | 3.20316302 |
| 14 | Lymphangioma (HP:0100764) | 3.16938655 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.14614913 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.10178697 |
| 17 | Hepatoblastoma (HP:0002884) | 3.07924249 |
| 18 | Spinal rigidity (HP:0003306) | 3.06356366 |
| 19 | Cervical subluxation (HP:0003308) | 3.06260852 |
| 20 | Skin nodule (HP:0200036) | 3.05076784 |
| 21 | Ketosis (HP:0001946) | 3.02358864 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.01994180 |
| 23 | Epidermoid cyst (HP:0200040) | 3.01540934 |
| 24 | Abnormality of the lower motor neuron (HP:0002366) | 3.01149486 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00982635 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95739554 |
| 27 | Wormian bones (HP:0002645) | 2.92900423 |
| 28 | Vertebral compression fractures (HP:0002953) | 2.92139133 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.90349725 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.82355459 |
| 31 | Hyperammonemia (HP:0001987) | 2.79714151 |
| 32 | Blue sclerae (HP:0000592) | 2.72858514 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.68936405 |
| 34 | Abnormality of complement system (HP:0005339) | 2.67052691 |
| 35 | Soft skin (HP:0000977) | 2.65512098 |
| 36 | Gout (HP:0001997) | 2.64656970 |
| 37 | Ulnar bowing (HP:0003031) | 2.64160036 |
| 38 | Dilatation of the ascending aorta (HP:0005111) | 2.63936333 |
| 39 | Hyperglycinuria (HP:0003108) | 2.63523379 |
| 40 | Genu recurvatum (HP:0002816) | 2.62586454 |
| 41 | Hyperacusis (HP:0010780) | 2.62031103 |
| 42 | Neonatal short-limb short stature (HP:0008921) | 2.60416863 |
| 43 | Turricephaly (HP:0000262) | 2.56174600 |
| 44 | Ketoacidosis (HP:0001993) | 2.54758548 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.54303412 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54303412 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 2.53604137 |
| 48 | Broad metatarsal (HP:0001783) | 2.52421783 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52388931 |
| 50 | Abnormality of the Achilles tendon (HP:0005109) | 2.51107449 |
| 51 | Joint hemorrhage (HP:0005261) | 2.49074802 |
| 52 | Mitral valve prolapse (HP:0001634) | 2.48981011 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.48393382 |
| 54 | Peritonitis (HP:0002586) | 2.47954788 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45589047 |
| 56 | Shallow orbits (HP:0000586) | 2.42640282 |
| 57 | Follicular hyperkeratosis (HP:0007502) | 2.39286229 |
| 58 | Mitral stenosis (HP:0001718) | 2.39047310 |
| 59 | Abnormality of dentin (HP:0010299) | 2.38996787 |
| 60 | Hypercholesterolemia (HP:0003124) | 2.36431392 |
| 61 | Mitral regurgitation (HP:0001653) | 2.34955212 |
| 62 | Hyperglycinemia (HP:0002154) | 2.33164300 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33147650 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.33147650 |
| 65 | Broad face (HP:0000283) | 2.32064592 |
| 66 | Myocardial infarction (HP:0001658) | 2.32043517 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.29182326 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.28528499 |
| 69 | Abnormal cartilage morphology (HP:0002763) | 2.28214713 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.27058244 |
| 71 | Hyperextensible skin (HP:0000974) | 2.22999991 |
| 72 | Fat malabsorption (HP:0002630) | 2.22326175 |
| 73 | Short nail (HP:0001799) | 2.21804215 |
| 74 | Joint laxity (HP:0001388) | 2.21667193 |
| 75 | Esophageal varix (HP:0002040) | 2.21647876 |
| 76 | Thin bony cortex (HP:0002753) | 2.21214934 |
| 77 | Overgrowth (HP:0001548) | 2.21210552 |
| 78 | Pseudobulbar signs (HP:0002200) | 2.20738322 |
| 79 | Natal tooth (HP:0000695) | 2.20573187 |
| 80 | Increased connective tissue (HP:0009025) | 2.18033402 |
| 81 | Macroorchidism (HP:0000053) | 2.15004325 |
| 82 | Distal lower limb amyotrophy (HP:0008944) | 2.14984268 |
| 83 | Premature rupture of membranes (HP:0001788) | 2.13629982 |
| 84 | Back pain (HP:0003418) | 2.12628629 |
| 85 | Aneurysm (HP:0002617) | 2.12178442 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.12145653 |
| 87 | Visceral angiomatosis (HP:0100761) | 2.10626241 |
| 88 | Spondylolisthesis (HP:0003302) | 2.10244700 |
| 89 | Spastic diplegia (HP:0001264) | 2.09676571 |
| 90 | Biconcave vertebral bodies (HP:0004586) | 2.09189673 |
| 91 | Achilles tendon contracture (HP:0001771) | 2.07745078 |
| 92 | Bowel diverticulosis (HP:0005222) | 2.06680281 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 2.06535657 |
| 94 | Distal upper limb amyotrophy (HP:0007149) | 2.04851609 |
| 95 | Upper limb amyotrophy (HP:0009129) | 2.04851609 |
| 96 | Advanced eruption of teeth (HP:0006288) | 2.03251226 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01420548 |
| 98 | Abnormality of the acetabulum (HP:0003170) | 2.00651942 |
| 99 | Malnutrition (HP:0004395) | 2.00465604 |
| 100 | Delayed CNS myelination (HP:0002188) | 1.99753720 |
| 101 | Slender build (HP:0001533) | 1.99053729 |
| 102 | Flat acetabular roof (HP:0003180) | 1.97210706 |
| 103 | Hemangiomatosis (HP:0007461) | 1.96347123 |
| 104 | Ankle contracture (HP:0006466) | 1.95089849 |
| 105 | Elbow flexion contracture (HP:0002987) | 1.92493510 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 1.92063333 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88841777 |
| 108 | Difficulty running (HP:0009046) | 1.87728582 |
| 109 | Hand muscle atrophy (HP:0009130) | 1.85432682 |
| 110 | Abnormal delivery (HP:0001787) | 1.85206910 |
| 111 | Wrist flexion contracture (HP:0001239) | 1.85005482 |
| 112 | Round ear (HP:0100830) | 1.84000585 |
| 113 | Abnormal ossification of hand bones (HP:0005921) | 1.83877056 |
| 114 | Amyloidosis (HP:0011034) | 1.83009734 |
| 115 | Neonatal onset (HP:0003623) | 1.82973427 |
| 116 | Long toe (HP:0010511) | 1.82585062 |
| 117 | Bilateral microphthalmos (HP:0007633) | 1.82456527 |
| 118 | Aortic regurgitation (HP:0001659) | 1.82358675 |
| 119 | Coxa vara (HP:0002812) | 1.81759219 |
| 120 | Disproportionate tall stature (HP:0001519) | 1.81057651 |
| 121 | Asymmetry of the thorax (HP:0001555) | 1.80372281 |
| 122 | Neoplasm of the heart (HP:0100544) | 1.78418351 |
| 123 | Arnold-Chiari malformation (HP:0002308) | 1.78012655 |
| 124 | Cardiovascular calcification (HP:0011915) | 1.76978348 |
| 125 | Difficulty climbing stairs (HP:0003551) | 1.76751101 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.76363476 |
| 127 | Camptodactyly of toe (HP:0001836) | 1.75464007 |
| 128 | Hemorrhage of the eye (HP:0011885) | 1.75297681 |
| 129 | Hypoventilation (HP:0002791) | 1.73208546 |
| 130 | Abnormality of carpal bone ossification (HP:0006257) | 1.73039961 |
| 131 | Wide anterior fontanel (HP:0000260) | 1.72224833 |
| 132 | Ectopia lentis (HP:0001083) | 1.72000722 |
| 133 | Coronal craniosynostosis (HP:0004440) | 1.71586453 |
| 134 | Generalized amyotrophy (HP:0003700) | 1.71266767 |
| 135 | Abnormality of the 4th metacarpal (HP:0010012) | 1.71109112 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.71054458 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70763735 |
| 138 | Spinal cord lesions (HP:0100561) | 1.70200765 |
| 139 | Syringomyelia (HP:0003396) | 1.70200765 |
| 140 | Insomnia (HP:0100785) | 1.69903868 |
| 141 | Right ventricular cardiomyopathy (HP:0011663) | 1.69654115 |
| 142 | Joint stiffness (HP:0001387) | 1.68500776 |
| 143 | Renal duplication (HP:0000075) | 1.67908732 |
| 144 | Bowing of the arm (HP:0006488) | 1.67553412 |
| 145 | Bowed forearm bones (HP:0003956) | 1.67553412 |
| 146 | Hypoplasia of the iris (HP:0007676) | 1.66852311 |
| 147 | Ankyloglossia (HP:0010296) | 1.66394389 |
| 148 | Congenital glaucoma (HP:0001087) | 1.65397453 |
| 149 | Abnormality of oral frenula (HP:0000190) | 1.65034101 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.64598116 |
| 151 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.64594012 |
| 152 | Infantile muscular hypotonia (HP:0008947) | 1.64423346 |
| 153 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.64386218 |
| 154 | Polycythemia (HP:0001901) | 1.64293926 |
| 155 | Abnormality of methionine metabolism (HP:0010901) | 1.64270161 |
| 156 | Renovascular hypertension (HP:0100817) | 1.63888275 |
| 157 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.63613937 |
| 158 | Aortic valve stenosis (HP:0001650) | 1.62205638 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.62019371 |
| 160 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.61092209 |
| 161 | Vascular calcification (HP:0004934) | 1.61022603 |
| 162 | Nonimmune hydrops fetalis (HP:0001790) | 1.60911758 |
| 163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.59950882 |
| 164 | Hamartoma of the eye (HP:0010568) | 1.59905638 |
| 165 | Bladder diverticulum (HP:0000015) | 1.58262247 |
| 166 | Aortic aneurysm (HP:0004942) | 1.56819254 |
| 167 | Hallux valgus (HP:0001822) | 1.56641304 |
| 168 | Status epilepticus (HP:0002133) | 1.56209271 |
| 169 | Focal segmental glomerulosclerosis (HP:0000097) | 1.55855606 |
| 170 | Cholelithiasis (HP:0001081) | 1.55556622 |
| 171 | Short 4th metacarpal (HP:0010044) | 1.55437544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.06377360 |
| 2 | TRIB3 | 3.79808387 |
| 3 | SIK1 | 3.28673932 |
| 4 | CDK12 | 2.87325467 |
| 5 | PKN2 | 2.63976302 |
| 6 | RIPK1 | 2.59969491 |
| 7 | LATS1 | 2.23236089 |
| 8 | SMG1 | 2.14322215 |
| 9 | FGFR4 | 2.12595913 |
| 10 | PDGFRA | 2.06913547 |
| 11 | MYLK | 1.98709244 |
| 12 | MAP3K10 | 1.91674307 |
| 13 | EPHA2 | 1.91160176 |
| 14 | TYRO3 | 1.87943412 |
| 15 | PTK6 | 1.84605636 |
| 16 | PRPF4B | 1.75945618 |
| 17 | TESK1 | 1.73731035 |
| 18 | FGFR2 | 1.71804608 |
| 19 | BCKDK | 1.71002773 |
| 20 | TTN | 1.65465888 |
| 21 | TGFBR2 | 1.64180678 |
| 22 | NTRK1 | 1.60358106 |
| 23 | DDR2 | 1.52203986 |
| 24 | NEK9 | 1.46852733 |
| 25 | EPHB2 | 1.43794948 |
| 26 | MAP3K7 | 1.43706917 |
| 27 | IRAK3 | 1.43517586 |
| 28 | EPHB1 | 1.39830792 |
| 29 | CAMK1D | 1.37495314 |
| 30 | LATS2 | 1.37380373 |
| 31 | ICK | 1.31522419 |
| 32 | CAMK1G | 1.31497060 |
| 33 | GRK6 | 1.30744333 |
| 34 | RPS6KA2 | 1.27134028 |
| 35 | PTK2 | 1.26413932 |
| 36 | MAP2K4 | 1.22165342 |
| 37 | FGFR3 | 1.18392854 |
| 38 | GRK5 | 1.16208322 |
| 39 | LIMK1 | 1.15476760 |
| 40 | MAP3K3 | 1.14297018 |
| 41 | MAP3K6 | 1.13993345 |
| 42 | WNK3 | 1.12548569 |
| 43 | MTOR | 1.10964678 |
| 44 | ERBB2 | 1.09417759 |
| 45 | RET | 1.06047123 |
| 46 | EEF2K | 1.04058328 |
| 47 | BMX | 1.03087350 |
| 48 | PAK3 | 1.02624163 |
| 49 | DAPK2 | 0.99405317 |
| 50 | PRKD3 | 0.99315136 |
| 51 | MAP3K9 | 0.97044141 |
| 52 | MAP2K3 | 0.96526799 |
| 53 | CSF1R | 0.96275741 |
| 54 | PRKCH | 0.95317205 |
| 55 | PAK6 | 0.94555939 |
| 56 | FER | 0.92179903 |
| 57 | KSR2 | 0.90256881 |
| 58 | INSRR | 0.90077639 |
| 59 | MARK2 | 0.88500797 |
| 60 | ARAF | 0.85695295 |
| 61 | PDGFRB | 0.85417316 |
| 62 | ROCK2 | 0.85325767 |
| 63 | TRPM7 | 0.85254367 |
| 64 | PRKG2 | 0.84728810 |
| 65 | MAPK7 | 0.79901154 |
| 66 | LRRK2 | 0.79817590 |
| 67 | WNK1 | 0.79766979 |
| 68 | LMTK2 | 0.79680941 |
| 69 | CAMK4 | 0.76714002 |
| 70 | CAMKK1 | 0.75763995 |
| 71 | MAP3K2 | 0.75371252 |
| 72 | PAK4 | 0.73897179 |
| 73 | MST1R | 0.72797492 |
| 74 | TAOK1 | 0.71000757 |
| 75 | STK38 | 0.69222668 |
| 76 | EPHA3 | 0.67914565 |
| 77 | FGFR1 | 0.66545386 |
| 78 | PAK2 | 0.65441971 |
| 79 | MET | 0.65413662 |
| 80 | FRK | 0.63175709 |
| 81 | DYRK1B | 0.62319249 |
| 82 | PHKG2 | 0.62124334 |
| 83 | PHKG1 | 0.62124334 |
| 84 | ROCK1 | 0.62121460 |
| 85 | TIE1 | 0.61861821 |
| 86 | MARK1 | 0.61651459 |
| 87 | PRKD1 | 0.61632329 |
| 88 | DMPK | 0.61563647 |
| 89 | GRK1 | 0.60844157 |
| 90 | ALK | 0.59420901 |
| 91 | TAOK2 | 0.59017686 |
| 92 | ERBB4 | 0.58472126 |
| 93 | MATK | 0.58352529 |
| 94 | MAP3K1 | 0.58191161 |
| 95 | RPS6KC1 | 0.57341927 |
| 96 | RPS6KL1 | 0.57341927 |
| 97 | MAPK12 | 0.56919049 |
| 98 | SGK3 | 0.56894786 |
| 99 | CDK6 | 0.55897240 |
| 100 | MAPKAPK3 | 0.55806216 |
| 101 | PRKAA1 | 0.55374902 |
| 102 | ILK | 0.55306082 |
| 103 | GSK3A | 0.55080913 |
| 104 | KDR | 0.55040712 |
| 105 | SIK2 | 0.54672226 |
| 106 | JAK1 | 0.54625828 |
| 107 | KSR1 | 0.53693452 |
| 108 | PRKCZ | 0.53352314 |
| 109 | SCYL2 | 0.52288597 |
| 110 | TAOK3 | 0.51584028 |
| 111 | STK10 | 0.51309157 |
| 112 | ZAP70 | 0.49314143 |
| 113 | MAP3K13 | 0.49189647 |
| 114 | NTRK2 | 0.49122597 |
| 115 | CSK | 0.49115669 |
| 116 | FLT3 | 0.48319705 |
| 117 | MAP3K8 | 0.47050982 |
| 118 | MOS | 0.46983025 |
| 119 | HIPK2 | 0.46379175 |
| 120 | JAK2 | 0.46363442 |
| 121 | DAPK3 | 0.45699160 |
| 122 | PRKAA2 | 0.44119225 |
| 123 | AKT3 | 0.44093663 |
| 124 | MAPK11 | 0.43012438 |
| 125 | STK3 | 0.42911136 |
| 126 | PIM2 | 0.42507501 |
| 127 | PRKD2 | 0.42500567 |
| 128 | PTK2B | 0.42413888 |
| 129 | ABL2 | 0.42329314 |
| 130 | PIK3CG | 0.41612407 |
| 131 | CDC42BPA | 0.40782134 |
| 132 | EPHA4 | 0.40530583 |
| 133 | PDPK1 | 0.39415232 |
| 134 | SRC | 0.37947305 |
| 135 | CAMK2G | 0.37750261 |
| 136 | IGF1R | 0.37215308 |
| 137 | MAP2K1 | 0.36934996 |
| 138 | RPS6KA6 | 0.33768463 |
| 139 | MAPKAPK2 | 0.31033608 |
| 140 | MELK | 0.30313333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.03684611 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47513346 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.91798020 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68441258 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65260827 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.40920448 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36553463 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32247231 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31294242 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23782688 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06502539 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97844711 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88524270 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86427752 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.81190438 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80085683 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.77642254 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.76849799 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67528522 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63148376 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59119352 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56999211 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50483455 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50319687 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49772590 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49251258 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47640865 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46506477 |
| 29 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44883713 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39245501 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.38195118 |
| 32 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.33997463 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33978820 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33895339 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30293387 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.30082441 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28619150 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.26737018 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20691027 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18641599 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17954202 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17155632 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16959467 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16509342 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16003560 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15128734 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.13120231 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11442887 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10749262 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08987422 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07427523 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06303137 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.03573560 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03281152 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02755638 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99518713 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96678792 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96308406 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95677852 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95246745 |
| 61 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.95189749 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92433865 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92061242 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91537519 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.91231092 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.90646325 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.88594438 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87483662 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.86846635 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86578724 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.86317215 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.85971426 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85365465 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84523286 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.83686760 |
| 76 | Pathways in cancer_Homo sapiens_hsa05200 | 0.83566999 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82410937 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82147337 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.79901675 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78967963 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76713293 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76142325 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.75598633 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.75094750 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72032628 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70397004 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70149489 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.68588672 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67163356 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67146142 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67016867 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63730566 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63383116 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62562969 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62068928 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61319342 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.61048253 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60662682 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60486708 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60434629 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60108011 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59890542 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59285849 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.58941821 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57517499 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.57362316 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55950259 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.54944633 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54594594 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53306940 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52775430 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52477714 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52190356 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51827444 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51779436 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50902248 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50125624 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.49181053 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49173141 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.48767366 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48184365 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48044414 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47702202 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46434976 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.44714283 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44709390 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43716480 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43432666 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43104656 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42913501 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42450148 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42373650 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.42295603 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41973439 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41759113 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40478977 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.39937299 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39931845 |
| 139 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37131351 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36753943 |
| 141 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36504823 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36098560 |
| 143 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34926248 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33884103 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33756369 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33027980 |
| 147 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32928081 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.32495368 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31119267 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30613741 |
| 151 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30344500 |
| 152 | Axon guidance_Homo sapiens_hsa04360 | 0.30081366 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30012538 |
| 154 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27010596 |
| 155 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.25208355 |
| 156 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23775490 |
| 157 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23074162 |
| 158 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22646667 |

